GSK2334470 (C09-0899-210)

Aladdin

Catalog No.: C09-0899-210
Manufacturer No.: G126481-5mg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Price: $96.38

List Price: $107.09

GSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM, with no activity at other close related AGC-kinases.A potent and selective PDK1 inhibitor that subsequently induces apoptotic cell death.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

GSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM, with no activity at other close related AGC-kinases.A potent and selective PDK1 inhibitor that subsequently induces apoptotic cell death. Specification: 0.95 MDL Number: MFCD21608525 Molecular Formula: C25H34N8O Molecular Weight: 462.59 PubChem CID: 46215815 Isomeric SMILES: C[C@@H]1CC[C@@H](CN1C2=NC(=NC(=C2)C3=CC4=C(C=C3)C(=NN4)N)NC)C(=O)NC5CCCCC5 Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/G126481-SCI_3ebd716e6377f0572c90660bcbfaccf2.pdf

UPC:: 12352005
Condition:: New
Availability:: 1 day
Weight:: 0.96 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: G126481-5mg
CAS:: 1227911-45-6
Product Size:: 5mg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."